Drugs Xagena
Amgen has informed physicians of important safety information for Prolia ( Denosumab ) and updates to the Prescribing Information.Prolia was originally approved by the FDA ( Food and Drug Administrati ...
The FDA ( Food and Drug Administration ) has updated healthcare professionals and the public on the potential drug interaction between Methylene Blue and serotonergic psychiatric medications. Most cas ...
The FDA ( Food and Drug Administration ) has updated information on the potential drug interaction between Linezolid ( Zyvox; in Europe: Zyvoxid ) and serotonergic psychiatric medications. Not all ser ...
The FDA ( Food and Drug Administration ) has reviewed the results from two FDA-sponsored epidemiological studies that evaluated the risk of neuropsychiatric adverse events associated with the smoking ...
Eli Lilly and Boehringer Ingelheim have received marketing authorization from the European Commission for Linagliptin 5 mg film-coated tablets ( Trajenta ) for the treatment of adults with type 2 diab ...
The FDA ( Food and Drug Administration ) has asked manufacturers of prescription combination products that contain Acetaminophen ( Paracetamol ) to limit the amount of Acetaminophen to no more than 32 ...
Heart disease is a common cause of serious illness and death in smokers and is often a reason for people to stop smoking. Varenicline ( Chantix, Champix ) is one of the most commonly used drugs to hel ...
The FDA ( Food and Drug Administration ) has notified healthcare professionals that children born to mothers who take the anti-seizure medication Valproate sodium or related products ( Valproic acid a ...
The FDA ( Food and Drug Administration ) has granted marketing approval for Corifact, Factor XIII Concentrate ( human ), for the routine prophylactic treatment of congenital factor XIII ( FXIII ) defi ...
The PhVWP ( Pharmacovigilance Working Party ) carried out a review of fluoroquinolones with regard to the risk of QT interval prolongation, triggered by discrepancies noted for some products between t ...
The FDA ( U.S. Food and Drug Administration ) has approved Zyclara ( Imiquimod ), a new topical cream for actinic keratoses ( AK ) on the face or balding scalp. Clinical studies have proved Zyclara ...
Chronic obstructive pulmonary disease ( COPD ) is a leading cause of death worldwide, and the rate of COPD-related death is increasing. No current drug therapy alters the progressive decline in lung f ...
Tribenzor is a combination of Amlodipine, Hydrochlorothiazide, and Olmesartan medoxomil. Amlodipine is a calcium channel blocker. Amlodipine is a peripheral arterial vasodilator. Hydrochlorothiazide i ...
Sunovion Pharmaceuticals has announced that the FDA ( Food and Drug Administration ) has approved Latuda ( Lurasidone HCl ) tablets for the treatment of schizophrenia.Latuda is an oral, once-daily aty ...
FDA ( Food and Drug Administration ) has informed the public that results from a study conducted in France ( the Santé Adulte GH Enfant [ SAGhE ] study ) found that persons with certain kinds of short ...
The FDA ( Food and Drug Administration ) has approved Zortress ( Everolimus ) oral tablets for the prevention of organ rejection of kidney transplants in adult patients at low-to-moderate immunologic ...
Zometa ( Zoledronic acid ) is indicated for the prevention of skeletal related events ( pathological fractures, spinal compression, radiation or surgery to bone, or tumor-induced hypercalcemia ) in pa ...
The FDA ( Food and Drug Administration ) has approved Tribenzor ( Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide ), a new three-in-one combination product taken once-daily for the treatment of ...
Investigational once-daily oral, direct factor Xa inhibitor, Edoxaban ( Lixiana ), was shown to be superior to Enoxaparin ( Lovenox ) in preventing venous thromboembolic ( VTE ) events in patients fol ...
On September 23, 2010, the FDA ( Food and Drug Administration ) announced that it would restrict access to Rosiglitazone ( Avandia ) through use of a Risk Evaluation and Mitigation Strategy, or REMS.U ...
Results from the phase III OPTIMAL study have shown that first-line Erlotinib ( Tarceva ) extended the time people with a distinct form of lung cancer lived without their disease getting worse ( progr ...
Preliminary results from a phase II study have shown that a combination of MetMAb, a unique monovalent antibody, with Erlotinib ( Tarceva ) nearly doubled the time people with high MET expressing non- ...
Roche has announced new Phase II efficacy data from the investigational compound GA101 ( RG 1759; Obinutuzumab ) in relapsed / refractory non-Hodgkin's lymphoma ( NHL ).GA101 is the first type II ...
The FDA ( Food and Drug Administration ) has announced that the Agency is recommending removing the breast cancer indication from the label for Avastin ( Bevacizumab ) because the drug has not been sh ...
A widely prescribed class of drugs is highly effective in reducing common bone fractures in people with osteoporosis, but an expert panel announced that these same drugs, when used long term, may be r ...
Provenge ( Sipuleucel-T ) is an autologous cellular immunotherapy designed to stimulate a patients own immune system against cancer. Provenge is manufactured in several steps. First the patients bl ...
Tolvaptan ( Samsca ) is an orally administered, nonpeptide, selective arginine vasopressin V(2) receptor antagonist that increases free water clearance, thereby correcting low serum sodium levels. ...
The high degree of selectivity of PLX4032 ( RG7204 ) enables substantial RAF/MEK/ERK pathway inhibition, which may be necessary to achieve significant tumor shrinkage and clinical response in patients ...
Findings from a new study show, compared to placebo, treatment with high-dose prescription Omega-3 fatty acids did not reduce the recurrence of symptomatic atrial fibrillation among patients with symp ...
An investigational drug, Anacetrapib, has raised HDL cholesterol by 138% and decreased LDL cholesterol by 40% without raising blood pressure. DEFINE ( Determining the EFficacy and Tolerability of C ...
The FDA ( Food and Drug Administration ) has approved Everolimus tablets ( Afinitor ) for the treatment of patients with advanced renal cell carcinoma after failure of treatment with Sunitinib or Sora ...
Osteoarthritis is the most common form of joint disease and the leading cause of pain and disability in the elderly. S-Adenosylmethionine ( SAMe; Samyr ) may be a viable treatment option but the evide ...
The FDA ( Food and Drug Administration ) issued a Follow-Up to the previous Early Communications issued in 2008, describing a potential increase in the risk of stroke, myocardial infarction, or death ...
Duloxetine is a balanced serotonin and noradrenaline reuptake inhibitor licensed for the treatment of major depressive disorders, urinary stress incontinence and the management of neuropathic pain ass ...
Cystic fibrosis is a genetic disorder with multiorgan effects. In a subgroup with pancreatic insufficiency malabsorption of the fat soluble vitamins ( A, D, E, K ) may occur. Vitamin D is involved in ...
Abatacept ( Orencia ) inhibits the co-stimulation of T cells and disrupts the inflammatory chain of events that leads to joint inflammation, pain, and damage in rheumatoid arthritis. Researchers at ...
A study has shown that Celecoxib ( Celebrex ) and other anti-inflammatory coxib medications may counter the positive effects of Acetylsalicylic acid ( Aspirin ) in preventing blood clots. The resea ...
In conjunction with EU regulatory authorities, including the MHRA, Cephalon has informed Healthcare Professional of the following new warnings and safety information for Provigil ( Modafinil ) re ...
In agreement with the EMEA ( European Medicines Agency ), F.Hoffmann-La Roche has informed HealthCare Professional of new safety information regarding CellCept ( Mycophenolate mofetil ). Isolated ...
Telbivudine ( Sebivo ) is a new nucleoside analogue that is indicated for treatment of chronic hepatitis B in adults with compensated liver disease and evidence of viral replication, persistently e ...
In a clinical study ( study 400 ) the use of InductOs ( Dibotermin alfa ) in acute open tibia fractures, as an adjunct to standard of care ( SOC ), using reamed intramedullary nails, has resulted in ...
Eli Lilly has informed Healthcare Professionals of important safety information and changes to the prescribing information for Celance ( Pergolide ) prompted by reports of fibrotic reactions, includ ...
Celgene, in agreement with the Committee for Medicinal Products for Human Use ( CHMP ) of the European Medicines Agency ( EMEA ) has informed Healthcare Professionals about the following new safety ...
The Healthcare Professionals have been informed about new safety information regarding the occurrence of cardiac valvulopathy / fibrotic disorders for the following medicines: Cabaser ( Caberg ...
Rituximab ( MabThera; US: Rituxan ) is a monoclonal antibody representing a glycosylated immunoglobulin indicated for the treatment of: - Non-Hodgkins lymphoma: in combination with ...
Taking regular Acetylsalicylic acid ( Aspirin ) and antioxidant supplements does not prevent myocardial infarctions even in high risk groups with diabetes and asymptomatic arterial disease, and Acet ...
The FDA ( Food and Drug Administration ) has completed its analysis of reports of suicidality ( suicidal behavior or ideation ) from placebo-controlled clinical trials of drugs used to treat epileps ...
The FDA ( Food and Drug Administration ) has approved the injectable drug Degarelix, the first new drug in several years for prostate cancer. Degarelix is intended to treat patients with advance ...
In the 2008, the FDA ( Food and Drug Administration ) has approved Bendamustine hydrochloride ( Treanda ), an intravenously administered alkylating agent, for the treatment of patients with indolent B ...
Bayer HealthCare and Genzyme, in collaboration with Health Canada, informed of important safety information regarding the use of MabCampath ( Alemtuzumab ) as consolidation therapy following combinati ...
